Cargando…

The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review

BACKGROUND: Methamphetamine/amphetamine use has sharply increased among people with opioid use disorder (OUD). It is therefore important to understand whether and how use of these substances may impact receipt of, and outcomes associated with, medications for OUD (MOUD). This systematic review ident...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frost, Madeline C., Lampert, Hannah, Tsui, Judith I., Iles-Shih, Matthew D., Williams, Emily C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504567/ https://www.ncbi.nlm.nih.gov/pubmed/34635170 http://dx.doi.org/10.1186/s13722-021-00266-2

Ejemplares similares

The Effectiveness of Topiramate in the Treatment of Amphetamine and Methamphetamine Use Disorder: A Randomized Controlled Trial
por: Moghaddam Sadegh, Amirali, et al.
Publicado: (2023)

Epigenetic landscape of amphetamine and methamphetamine addiction in rodents
por: Godino, Arthur, et al.
Publicado: (2015)

A Case of Amphetamine and Methamphetamine Intoxication in Cat
por: Chłopaś-Konowałek, Agnieszka, et al.
Publicado: (2022)

Efficacy and safety of psychostimulants for amphetamine and methamphetamine use disorders: a systematic review and meta-analysis
por: Bhatt, Meha, et al.
Publicado: (2016)

Associations Between Polysubstance Use Patterns and Receipt of Medications for Opioid Use Disorder Among Adults in Treatment for Opioid Use Disorder
por: Ford, Becky R., et al.
Publicado: (2021)

Association of Methamphetamine and Opioid Use With Nonfatal Overdose in Rural Communities
por: Korthuis, P. Todd, et al.
Publicado: (2022)

Association of clozapine treatment and rate of methamphetamine or amphetamine relapses and abstinence among individuals with concurrent schizophrenia spectrum and amphetamine use disorder: A retrospective cohort study
por: Rafizadeh, Reza, et al.
Publicado: (2023)

Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review
por: Siefried, Krista J., et al.
Publicado: (2020)

Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic
por: Jones, Christopher M., et al.
Publicado: (2022)

The impact of methamphetamine use on medications for opioid use disorder (MOUD) treatment retention: a scoping review
por: Russell, Cayley, et al.
Publicado: (2023)

Receipt of medications for opioid use disorder among youth engaged in primary care: data from 6 health systems
por: Bagley, Sarah M., et al.
Publicado: (2021)

Association Between Inflammatory Cytokines, Executive Function, and Substance Use in Patients With Opioid Use Disorder and Amphetamine-Type Stimulants Use Disorder
por: Wang, Tzu-Yun, et al.
Publicado: (2022)

Affinity improvement of a therapeutic antibody to methamphetamine and amphetamine through structure-based antibody engineering
por: Thakkar, Shraddha, et al.
Publicado: (2014)

Association of Receipt of Opioid Use Disorder–Related Telehealth Services and Medications for Opioid Use Disorder With Fatal Drug Overdoses Among Medicare Beneficiaries Before and During the COVID-19 Pandemic
por: Jones, Christopher M., et al.
Publicado: (2023)

Differences in receipt of opioid agonist treatment and time to enter treatment for opioid use disorder among specialty addiction programs in the United States, 2014-17
por: Yang, Justin C., et al.
Publicado: (2019)

The Effects of Amphetamine and Methamphetamine on the Release of Norepinephrine, Dopamine and Acetylcholine From the Brainstem Reticular Formation
por: Ferrucci, Michela, et al.
Publicado: (2019)

Increasing rates of methamphetamine/amphetamine-involved overdose hospitalizations in Washington State, 2010–2017
por: Njuguna, Henry, et al.
Publicado: (2021)

Effects of amphetamine on the human brain opioid system – a positron emission tomography study
por: Guterstam, Joar, et al.
Publicado: (2013)

Negative Impact of Amphetamine-Type Stimulant Use on Opioid Agonist Treatment Retention in Ontario, Canada
por: Morin, Kristen A., et al.
Publicado: (2021)

Hybrid Solid-Phase Extraction for Selective Determination of Methamphetamine and Amphetamine in Dyed Hair by Using Gas Chromatography–Mass Spectrometry
por: Kwon, Nam Hee, et al.
Publicado: (2019)

A Human Oral Fluid Assay for D- and L- Isomer Detection of Amphetamine and Methamphetamine Using Liquid-Liquid Extraction
por: Robbins, Brian, et al.
Publicado: (2022)

Prescription amphetamines in people with opioid use disorder and co-occurring psychostimulant use disorder initiating buprenorphine: an analysis of treatment retention and overdose risk
por: Tardelli, Vitor, et al.
Publicado: (2023)

Use of methamphetamine and alcohol among people with opioid use disorder and HIV in Vietnam: a qualitative study
por: Edsall, Andrew, et al.
Publicado: (2021)

Does illicit amphetamine seizures quantity associated with amphetamine use disorder related admissions in Saudi Arabia?
por: Ramadan, Majed, et al.
Publicado: (2023)

Use of and Retention on Video, Telephone, and In-Person Buprenorphine Treatment for Opioid Use Disorder During the COVID-19 Pandemic
por: Frost, Madeline C., et al.
Publicado: (2022)

Frequency of Psychiatric Disorders in Children of Opioid or Methamphetamine-Dependent Patients
por: Parvaresh, Noushin, et al.
Publicado: (2015)

Characteristic changes in EEG spectral powers of patients with opioid-use disorder as compared with those with methamphetamine- and alcohol-use disorders
por: Minnerly, Christopher, et al.
Publicado: (2021)

Argon prevents the development of locomotor sensitization to amphetamine and amphetamine-induced changes in mu opioid receptor in the nucleus accumbens
por: David, Hélène N, et al.
Publicado: (2014)

Categorization of Cytochrome P4502D6 Activity Score by Urinary Amphetamine/Methamphetamine Ratios
por: Chaichana, Jatuporn, et al.
Publicado: (2022)

Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings
por: Frost, Madeline C., et al.
Publicado: (2023)

Receipt of Substance Use Counseling Among Ambulatory Patients Prescribed Opioids in the United States
por: Evoy, Kirk E, et al.
Publicado: (2020)

Trajectories and correlates of opioid prescription receipt among patients experiencing interpersonal violence
por: Williams, Jessica R., et al.
Publicado: (2022)

Histone modifications in cocaine, methamphetamine and opioids
por: Cheng, Junzhe, et al.
Publicado: (2023)

Amphetamine- and methamphetamine-induced hyperthermia: Implications of the effects produced in brain vasculature and peripheral organs to forebrain neurotoxicity
por: Bowyer, John F, et al.
Publicado: (2014)

The role of the GABA system in amphetamine-type stimulant use disorders
por: Jiao, Dongliang, et al.
Publicado: (2015)

Correlates of Aggression in Men With Methamphetamine Use Disorder: Childhood Trauma and Methamphetamine-Use Characteristics
por: Liu, Mengqi, et al.
Publicado: (2022)

Blunted Endogenous Opioid Release Following an Oral Amphetamine Challenge in Pathological Gamblers
por: Mick, Inge, et al.
Publicado: (2016)

Giant Pheochromocytoma Diagnosis Confounded by Amphetamine Use
por: Amin, Shreya, et al.
Publicado: (2023)

Epigenetic Landscape of Methamphetamine Use Disorder
por: Cadet, Jean Lud, et al.
Publicado: (2021)

Association Between State Opioid Prescribing Cap Laws and Receipt of Opioid Prescriptions Among Children and Adolescents
por: Stone, Elizabeth M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h25lf22ob82pms7je13ohnfm39